trastuzumab
Trastuzumab emtansine: Uses, Interactions, Mechanism of Action
Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease
เว็บไซต์ trastuzumab Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease trastuzumab Trastuzumab deruxtecan is an effective new treatment for patients with HER2-positive metastatic breast cancer who have been previously treated
trastuzumab Trastuzumab is a monoclonal antibody targeted against the HER2 tyrosine kinase receptor The majority of patients with metastatic breast Trastuzumab deruxtecan provides durable benefits to patients with heavily pretreated HER2 Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease
ไม่สามารถโหลดการรับสินค้าได้ ความพร้อมใช้งาน
